Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II)

American Journal of Cardiology

Volumn 96, Issue 5, 2005, Pages 691-695

  Brodine, William N ^a   Tung, Robert T ^a   Lee, John K ^a   Hockstad, Eric S ^a   Moss, Arthur J ^b   Zareba, Wojciech ^b   Hall, W Jackson ^b   Andrews, Mark ^b   McNitt, Scott ^b   Daubert, James P ^b  

^a Research Medical Center Brookside Campus   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CELIPROLOL; LABETALOL; METOPROLOL; NADOLOL; NEBIVOLOL; PROPRANOLOL; TIMOLOL;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; HEART ATRIUM FIBRILLATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL RATE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ATENOLOL; CARBAZOLES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METOPROLOL; MYOCARDIAL ISCHEMIA; PROPANOLAMINES; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL RATE; TACHYCARDIA; TREATMENT OUTCOME;

EID: 23944514751     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.04.046     Document Type: Article

References (17)

1. D.V. Exner, J.A. Reiffel, A.E. Epstein, R. Ledingham, M.J. Reitner, Q. Yao, H.J. Duff, D. Follmann, E. Schron, H.L. Greene Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia J Am Coll Cardiol 34 1999 325 333
2. K.E. Ellison, G.E. Hafley, K. Hickey, J. Kellen, J. Coromilas, K.M. Stein, K.L. Lee, A.E. Buxton MUSTT Investigators Effect of β-blocking therapy on outcome in the Multicenter Unsustained Tachycardia Trial (MUSTT) Circulation 106 2002 2694 2699
3. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, M.L. Andrews Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
4. β-Blocker Heart Attack Trial Research Group A randomized trial of propranolol in patients with acute myocardial infarction JAMA 247 1982 1707 1714
5. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
6. CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomized trial Lancet 353 1999 9 13
7. P.A. Heidenreich, T.T. Lee, B.M. Massie Effect of beta-blockade on mortality in patients with heart failure a meta-analysis of randomized clinical trials J Am Coll Cardiol 30 1997 27 34
8. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert, N.H. Shusterman The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
9. H.L. Kennedy, M.M. Brooks, A.H. Barker, R. Bergstrand, M.L. Huther, D.S. Beanlands, J.T. Bigger, S. Goldstein Beta-blocker therapy in the Cardiac Arrhythmia Suppression Trial Am J Cardiol 74 1994 674 680
10. S. Goldstein, H.L. Kennedy, C. Hall, J.L. Anderson, M. Gheorghiade, S. Gottleib, M. Jessup, R.P. Karlsberg, G. Friday, L. Haskell Metoprolol CR/XL in patients with heart failure a pilot study examining the tolerability, safety, and effect on left ventricular ejection fraction Am Heart J 138 1999 1158 1165
11. J. McMurray, L. Kober, J. Lopez-Sendon, W. Remme, N. Sharpe, I. Ford Antiarrhythmic effect of carvedilol after acute myocardial infarction J Am Coll Cardiol 45 2005 525 530
12. M.J. Reiter, J.A. Reiffel Importance of beta blockade in the therapy of serious ventricular arrhythmias Am J Cardiol 82 1998 91 99
13. D. Aronson, A.J. Burger Concomitant β-blocker therapy is associated with a lower occurrence of ventricular arrhythmias in patients with decompensated heart failure J Card Failure 8 2002 79 85
14. G. Cice, E. Tagliamonte, L. Ferrara, A. Iacono Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy double-blind, randomized, placebo-controlled study Eur Heart J 21 2000 1259 1264
15. S. Reiken, S.H.T. Wehrens, J.A. Vest, A. Barbone, S. Klotz, D. Mancini, D. Burkoff, A.R. Marks Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure Circulation 107 2003 2459 2466
16. J.L. Anderson, L.A. Karagounis, M. Roskelley, J.S. Osborn, D. Handrahan Effect of prophylactic antiarrhythmic therapy on time to implantable cardioverter-defibrillator discharge in patients with ventricular tachyarrhythmias Am J Cardiol 73 1994 683 687
17. J.H. Levine, E.D. Mellits, R.A. Baumgardner, E.P. Veltri, M. Mower, L. Grunwald, T. Guarnieri, D. Aarons, L.S. Briffith Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators Circulation 84 1991 558 566